Literature DB >> 16401619

A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17.

Ian R Mackenzie1, Matthew Baker, Gemma West, John Woulfe, Najeeb Qadi, Jennifer Gass, Ashley Cannon, Jennifer Adamson, Howard Feldman, Caroline Lindholm, Stacey Melquist, Rachel Pettman, A Dessa Sadovnick, Emily Dwosh, Sidney W Whiteheart, Michael Hutton, Stuart M Pickering-Brown.   

Abstract

Over 30 different mutations have now been identified in MAPt that cause frontotemporal dementia (FTD). However, there are several families with FTD that show definite linkage to the region on chromosome 17 that contains MAPt, in which no mutation(s) has been identified. Although these families could have a complex mutation of the MAPt locus that has evaded detection it is also possible that another gene in this region is associated with FTD. This possibility is supported by neuropathological findings in these families, which consist of neuronal inclusions that are immunoreactive for ubiquitin (ub-ir) but not for tau. In addition to neuronal cytoplasmic inclusions, several chromosome 17-linked families are reported to have ub-ir neuronal intranuclear inclusions (NII); a finding which is uncommon in sporadic FTD. Here, we describe detailed clinical and neuropathological findings in a new large, multigenerational family with autosomal dominant FTD and autopsy proven tau-negative, ub-ir neuronal cytoplasmic and intranuclear inclusions. We have demonstrated that this family is linked to a 19.06 cM region of chromosome 17q21 with a maximum multipoint LOD score of 3.911 containing MAPt. By combining the results of our genetic analysis with those previously published for other families with similar pathology, we have further refined the minimal region to a 3.53 cM region of chromosome 17q21. We did not identify point mutations in MAPt by direct sequencing or any gross MAPt gene alterations using fluorescent in situ hybridization. In addition, tau protein extracted from members of this family was unremarkable in size and quantity as assessed by western blotting. Neuropathological characterization of the ub-ir NII in this family shows that they are positive for promyelocytic leukaemia protein (PML) and SUMO-1 that suggests that these inclusions form in the nuclear body and suggests a possible mechanism of neurodegeneration in tau-negative FTD linked to chromosome 17q21.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401619     DOI: 10.1093/brain/awh724

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  30 in total

Review 1.  Developmental neurogenetics and multimodal neuroimaging of sex differences in autism.

Authors:  Christina Chen; John Darrell Van Horn
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

2.  Prominent phenotypic variability associated with mutations in Progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Neill R Graff-Radford; Thomas Krefft; Andrew R Frank; Clifford R Jack; Maria Shiung; David S Knopman; Keith A Josephs; Sotirios A Parashos; Rosa Rademakers; Mike Hutton; Stuart Pickering-Brown; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Robert J Ivnik; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2007-10-18       Impact factor: 4.673

Review 3.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

4.  Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Maria Shiung; David S Knopman; Rosa Rademakers; Mike Hutton; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Ronald C Petersen
Journal:  Arch Neurol       Date:  2010-02

5.  Cognitive impairment in lacunar strokes: the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Raymond Costello; Leslie A McClure; Stephen L Holliday; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

6.  Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.

Authors:  Lena Skoglund; RoseMarie Brundin; Tommie Olofsson; Hannu Kalimo; Sofie Ingvast; Elin S Blom; Vilmantas Giedraitis; Martin Ingelsson; Lars Lannfelt; Hans Basun; Anna Glaser
Journal:  Neurogenetics       Date:  2008-10-15       Impact factor: 2.660

7.  Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

Authors:  Chiara Fenoglio; Daniela Galimberti; Francesca Cortini; John S K Kauwe; Carlos Cruchaga; Eliana Venturelli; Chiara Villa; Maria Serpente; Diego Scalabrini; Kevin Mayo; Laura M Piccio; Francesca Clerici; Diego Albani; Claudio Mariani; Gianluigi Forloni; Nereo Bresolin; Alison M Goate; Elio Scarpini
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.

Authors:  Albert Lladó; Raquel Sánchez-Valle; Maria Jesús Rey; Mario Ezquerra; Eduardo Tolosa; Isidro Ferrer; José Luis Molinuevo
Journal:  J Neurol       Date:  2008-03-25       Impact factor: 4.849

Review 9.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

10.  Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.

Authors:  C Wider; S Melquist; M Hauf; A Solida; S A Cobb; J M Kachergus; J Gass; K D Coon; M Baker; A Cannon; D A Stephan; D F Schorderet; J Ghika; P R Burkhard; G Kapatos; M Hutton; M J Farrer; Z K Wszolek; F J G Vingerhoets
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.